Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process

Area of Science:

• Neuroscience
• Molecular Biology
• Electrophysiology

Background:

• Cannabinoid receptor agonists are known to increase voltage-dependent potassium A-current (IA) in hippocampal cells.
• Cannabinoid receptors are linked to the inhibition of adenylate cyclase, suggesting a potential role for cyclic adenosine monophosphate (cAMP) in mediating their effects.

Purpose of the Study:

• To investigate whether cannabinoid receptor modulation of voltage-dependent IA is mediated by a cAMP-dependent process.
• To elucidate the role of cAMP in the observed effects of cannabinoid receptor activation on IA.

Main Methods:

• Electrophysiological recordings in cultured hippocampal cells to measure IA.
• Application of cAMP analogs (8-bromo-cAMP), adenylate cyclase stimulants (forskolin), and phosphodiesterase inhibitors (3-isobutyl-1-methylxanthine).
• Direct assays of intracellular cAMP levels and pertussis toxin sensitivity experiments.

Main Results:

• Cannabinoid receptor agonists increased IA, while cAMP analogs and forskolin produced opposite shifts.
• WIN 55,212-2, a cannabinoid agonist, reversed forskolin's effects on IA.
• Cannabinoids inhibited forskolin-stimulated cAMP production by 50% in a pertussis toxin-sensitive manner.

Conclusions:

• Cannabinoid receptor-mediated changes in IA are likely due to the inhibition of adenylate cyclase and subsequent reduction in cAMP levels.
• Modulation of IA conductance properties by cannabinoid receptors involves the regulation of intracellular cAMP concentrations.